Clinical Trial Update: Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)

View source ↗

Summary

The ACE polymorphism and acute renal failure trial (ECAREA) sponsored by University Hospital, Caen has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Kidney Failure

Snippet

Sponsor: University Hospital, Caen | Conditions: Kidney Failure, Acute, Critical Illness | Status: TERMINATED